STAT+: Pharmalittle: Purdue bankruptcy plan is approved but appeals expected; FDA warns about safety risks with arthritis drugs

Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascot is sniffing about in search of varmint. As for us, we are as busy as ever hunting and gathering items of interest. We trust you have your own hectic agendas. So join us as we hoist the ever-present cup of stimulation and attack the to-do list. Have a grand day, everyone, and do stay in touch. …

After two years of contentious bargaining, a U.S. bankruptcy court judge approved a controversial plan that will dissolve Purdue Pharma, which has been blamed for triggering a widespread opioid crisis, and shield members of the Sackler family who control the company from future lawsuits, STAT reports. The settlement calls for some Sackler family members to contribute more than $4.3 billion over a decade to compensate people, local governments, and tribal communities that were harmed by the OxyContin painkiller. Appeals are expected.

Continue to STAT+ to read the full story…

STAT+: Pharmalittle: Purdue bankruptcy plan is approved but appeals expected; FDA warns about safety risks with arthritis drugs

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top